HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Fredun Pharmaceuticals Ltd Stock Comparison

Aurobindo Pharma Ltd vs Fredun Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 30, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1144 as of 30 Jun 10:13.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Fredun Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Fredun Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Aurobindo Pharma Ltd for the Mar '25 is ₹ 8516 crore as compare to the Dec '24 revenue of ₹ 8137 crore. This represent the growth of 4.66% The revenue of Fredun Pharmaceuticals Ltd for the Mar '25 is ₹ 167.41 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16%.
  • The ebitda of Aurobindo Pharma Ltd for the Mar '25 is ₹ 1894 crore as compare to the Dec '24 ebitda of ₹ 1736 crore. This represent the growth of 9.08% The ebitda of Fredun Pharmaceuticals Ltd for the Mar '25 is ₹ 17.25 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 902.83 crore over 8 quarters. This represents a CAGR of 25.89% The net profit of Fredun Pharmaceuticals Ltd changed from ₹ 6 crore to ₹ 6 crore over 1 quarters. This represents a CAGR of 0.00% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Fredun Pharmaceuticals Ltd changed from 13.86 % on March 2020 to 2.11 % on March 2024 . This represents a CAGR of -31.37% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Fredun Pharmaceuticals Ltd

  • Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94.
  • The Company was promoted by Nariman Medhora and Daulat N Medhora.
  • The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
  • Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
  • The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

Aurobindo Pharma Ltd News Hub

News

Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility

Aurobindo Pharma announced that its wholly owned step-down subsidiary, Lyfius Pharma has r...

Read more

30 Jun 2025 09:29

News

Aurobindo Pharma Ltd spurts 0.22%, up for fifth straight session

Aurobindo Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs ...

Read more

26 Jun 2025 13:00

News

Aurobindo Pharma gets UK MHRA approval for neutropenia treatment drug Dyrupeg

Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a ...

Read more

25 Jun 2025 12:51

News

CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg'

Aurobindo Pharma announced that CuraTeQ Biologics s.r.o., a wholly owned step-down subsidi...

Read more

24 Jun 2025 19:01

News

Aurobindo Pharma Ltd down for fifth straight session

Aurobindo Pharma Ltd is down for a fifth straight session today. The stock is quoting at R...

Read more

17 Jun 2025 13:35

News

Aurobindo Pharma's US arm incorporates Cresedemo Pharma

The purpose of incorporating this new entity is to expand the company's pharmaceutical pro...

Read more

16 Jun 2025 08:40

Fredun Pharmaceuticals Ltd News Hub

News

Board of Fredun Pharmaceuticals recommends final dividend

Fredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

31 May 2025 12:29

News

Fredun Pharmaceuticals declare Quarterly Result

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

23 May 2025 20:27

News

Fredun wins order from Tamil Nadu Medical Services Corporation

Fredun Pharmaceuticals has been awarded a significant tender by the Tamil Nadu Medical Ser...

Read more

09 Apr 2025 20:52

News

Fredun Pharmaceuticals announces its foray into large animal veterinary segment

Fredun Pharmaceuticals announced its foray into the large animal veterinary segment, under...

Read more

12 Mar 2025 10:37

News

Fredun Pharmaceuticals to table results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 F...

Read more

23 Jan 2025 11:28

News

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 ...

Read more

16 Oct 2024 11:59

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Fredun Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Fredun Pharmaceuticals Ltd?

Market cap of Aurobindo Pharma Ltd is 65,795 Cr while Market cap of Fredun Pharmaceuticals Ltd is 382 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd?

The stock performance of Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd?

As of June 30, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1122.9. On the other hand, Fredun Pharmaceuticals Ltd stock price is INR ₹811.1.

How do dividend payouts of Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Fredun Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions